Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Myskowski

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Drugs in Dermatology : JDD|December 27, 2018
Low-Grade Cutaneous B-cell Lymphoma in African American PatientsShamir Geller, Melissa Pulitzer, Patricia Myskowski, et al.
Journal of the American Academy of Dermatology|April 17, 2007
In vivo reflectance confocal microscopy of mycosis fungoides: A preliminary studyAnna Liza C Agero, Melissa Gill, Marco Ardigo, et al.
Cancer|March 17, 2007
Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphomaDavid J Straus, Madeleine Duvic, Timothy Kuzel, et al.
Journal of the American Academy of Dermatology|May 4, 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and managementYuna Oh, Joseph R Stoll, Alison Moskowitz, et al.
Clinical Genitourinary Cancer|October 10, 2009
Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castration-resistant prostate cancerSusan F Slovin, W Kevin Kelly, Andrew Wilton, et al.
Journal of the American Academy of Dermatology|October 3, 2006
Dermatologic side effects associated with the epidermal growth factor receptor inhibitorsAnna Liza C Agero, Stephen W Dusza, Cristiane Benvenuto-Andrade, et al.
Journal of the American Academy of Dermatology|May 3, 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosisJoseph R Stoll, Jonathan Willner, Yuna Oh, et al.
Histopathology|June 13, 2018
T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disordersMelissa Pulitzer, Shamir Geller, Erica Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World CohortRachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2011
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populationsNeha Mehta, Alan S Wayne, Youn H Kim, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Drugs in Dermatology : JDD|December 27, 2018
Low-Grade Cutaneous B-cell Lymphoma in African American PatientsShamir Geller, Melissa Pulitzer, Patricia Myskowski, et al.
Journal of the American Academy of Dermatology|April 17, 2007
In vivo reflectance confocal microscopy of mycosis fungoides: A preliminary studyAnna Liza C Agero, Melissa Gill, Marco Ardigo, et al.
Cancer|March 17, 2007
Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphomaDavid J Straus, Madeleine Duvic, Timothy Kuzel, et al.
Journal of the American Academy of Dermatology|May 4, 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and managementYuna Oh, Joseph R Stoll, Alison Moskowitz, et al.
Clinical Genitourinary Cancer|October 10, 2009
Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castration-resistant prostate cancerSusan F Slovin, W Kevin Kelly, Andrew Wilton, et al.
Journal of the American Academy of Dermatology|October 3, 2006
Dermatologic side effects associated with the epidermal growth factor receptor inhibitorsAnna Liza C Agero, Stephen W Dusza, Cristiane Benvenuto-Andrade, et al.
Journal of the American Academy of Dermatology|May 3, 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosisJoseph R Stoll, Jonathan Willner, Yuna Oh, et al.
Histopathology|June 13, 2018
T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disordersMelissa Pulitzer, Shamir Geller, Erica Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World CohortRachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 18, 2011
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populationsNeha Mehta, Alan S Wayne, Youn H Kim, et al.
Pageof 2